TAK-580 Uses, Dosage, Side Effects and more
TAK-580 is under investigation in clinical trial NCT02723006 (Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of Investigational Treatments in Combination With Standard of Care Immune Checkpoint Inhibitors in Participants With Advanced Melanoma).
| Trade Name | TAK-580 |
| Generic | TAK-580 |
| Type | |
| Formula | C17H12Cl2F3N7O2S |
| Weight | Average: 506.29 Monoisotopic: 505.0102337 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
